MedTrace Logo

Contrast Enhanced Ultrasound For The Evaluation Of Focal Liver Lesions

NCT01329458 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2011-04-06

No results posted yet for this study

Summary

The aim of the study is to assess the value of contrast enhanced ultrasound in the evaluation of de novo focal liver lesions in clinical practice, in a prospective multi-center design.

Conditions

  • Focal Nodular Hyperplasia of Liver
  • Toxic Liver Disease With Focal Nodular Hyperplasia
  • Liver Metastases

Sponsors & Collaborators

  • Centrul de Cercetare in Gastroenterologie si Hepatologie, Craiova

    collaborator UNKNOWN

  • Clinica de Gastroenterologie si Hepatologie, UMF Timisoara

    collaborator UNKNOWN

  • Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor

    collaborator OTHER

  • Institutul Clinic Fundeni

    collaborator OTHER

  • Clinica de Gastroenterologie Constanta

    collaborator UNKNOWN

  • Societatea Romana de Ultrasonografie in Medicina si Biologie

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01329458 on ClinicalTrials.gov